Background/Aim-Matrilysin is one of the matrix metalloproteinases that has
a critical role in tumour invasion, and is often expressed in gastrointesti
nal cancers. The aim of this study was to examine the role of matrilysin in
metastasis of human colorectal cancers.
Patients (Subjects)/Methods-The relation between matrilysin expression and
Dukes's type was investigated immunohistochemically in 83 surgically resect
ed colorectal cancers, including five with liver metastasis. Moreover, the
effects of matrilysin on the in vivo invasive and metastatic potential of c
olon cancer cells transfected with matrilysin cDNA were examined after subc
utaneous injection into SCID mice.
Results-In 46% of primary and all of metastatic liver tumours, over 10% of
cancer cells were stained positively for matrilysin. The expression of matr
ilysin correlated significantly with the presence of nodal or distant metas
tases (p<0.05). In addition, matrilysin transfectants formed invasive tumou
rs and multiple liver metastases in SCID mice, without producing any signif
icant difference in the subcutaneous tumour growth from mock transfectants.
Casein zymography showed that the invading and metastasised tumours showed
conspicuous matrilysin activity, which correlated with the number of metas
tatic lesions (p<0.001).
Conclusions-Matrilysin showed a correlation with metastasis in a cohort of
83 colorectal cancer patients and marked metastatic potentiation in human c
olorectal cancer xenografts, indicating that it may play a critical role in
the metastatic pathway of colorectal cancers.